Moreover, in a comprehensive immunogenomic analysis of AML, mutations of NPM1 and FLT3 preferentially associated with low T-cell cytolytic activity and a reduced expression of HLA-II (and/or related genetic determinants of HLA-II expression, as CIITA) [126]. Here, NPM1 is linked to acute myeloid leukemia.